FOXO3 and type 2 diabetes mellitus: In this context, metformin, a biguanide drug that has long been used to treat type 2 diabetes due to its robust glucose-lowering effects, well-established safety profile, and relatively low cost, is known to activate the AMPK- and FOXO3-dependent pathways [19,20,23,24].